© 2020 MJH Life Sciences and Urology Times. All rights reserved.
Voiding Dysfunction
How do gender differences affect incontinence management?
February 25, 2020
Urologists must differentiate between bladder outlet obstruction and pure OAB in male patients, according to Osvaldo F. Padron, MD.
Minimally invasive treatments grab BPH spotlight
January 30, 2019
Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.
Water vapor thermal Tx modestly improves BPH symptoms
January 03, 2019
Convective radiofrequency water vapor thermal therapy (Rezum) can modestly improve symptoms of BPH, according to Daniel Mollengarden, MD.
OAB patients continue medical therapy unnecessarily
November 20, 2018
A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.
Nearly 30% of U.S. women report nocturia
November 20, 2018
Nocturia appears to be highly prevalent in the United States, with almost 30% of all women reporting significant nocturia, according to new data reported at the AUA annual meeting in San Francisco.
Data shift thinking on nocturia’s causes, treatment
November 20, 2018
Waking up at night to urinate is by far the most bothersome lower urinary tract symptom.
BPH procedures and med use: Two sides of a coin
November 14, 2018
"When analyzing efficacy of minimally invasive/surgical therapies for lower urinary tract symptoms secondary to BPH, we appropriately focus on subjective criteria and objective criteria. While we discuss retreatment rates, we don’t measure failure of therapies by how many men restart LUTS/BPH medications," writes Steven A. Kaplan, MD.
Which BPH procedures best reduce need for meds?
November 14, 2018
Tissue-eliminating procedures outperform tissue-necrosing procedures for reducing the need for medication in patients with benign prostatic enlargement, researchers say.
Non-head MRI found safe in patients undergoing SNM
November 07, 2018
The therapeutic efficacy of sacral neuromodulation was not affected by non-head magnetic resonance imaging scans in a recent study.